Core Viewpoint - The company is focusing on enhancing operational efficiency and service quality in response to industry policy changes, particularly in medical insurance payment reforms [1] Group 1: Company Strategy - The company plans to strengthen cost control and improve operational efficiency while expanding service scale in a structured manner [1] - A differentiated strategy will be employed to build competitive advantages and enhance service value [1] - The company aims to optimize its capital structure through diversified financing channels to improve debt structure and reduce financial costs [1] Group 2: Financial Performance - As of October 21, 2025, the company's stock closed at 4.86 yuan, with a 0.62% increase and a trading volume of 12.17 million shares, amounting to a transaction value of 58.96 million yuan [1] - The company's current asset-liability ratio is considered reasonable, and it has sufficient comprehensive credit exposure [1] Group 3: Project Updates - The proton therapy center at Xi'an International Medical Center Hospital, the first of its kind in Northwest China, is under construction and will commence operations upon obtaining necessary administrative approvals [1] Group 4: Market Sentiment - On October 21, the main funds experienced a net outflow of 2.26 million yuan, accounting for 3.84% of the total transaction value [2] - Retail investors saw a net outflow of 0.34 million yuan, representing 0.58% of the total transaction value [2]

（文章来源：深圳商报） 近日，深圳质子治疗中心正式启用。作为华南地区首个集医疗、科研、教学于一体的国际化质子治疗机 构，该中心依托全球领先的质子放射治疗技术，为肿瘤患者提供"精准、高效、低损伤"的尖端医疗服 务，深圳肿瘤放射治疗正式迈入质子治疗时代。相较传统放射治疗，质子治疗可以最大限度减少对正常 组织的损伤，降低对生长发育的影响及远期并发症（包括第二原发肿瘤）的风险，尤其适用于紧邻脑、 脊髓、眼睛等关键功能器官的肿瘤以及儿童肿瘤的治疗。 ...